mRNA workshop
Meeting category
Date(s)
27 Apr 2023 - 28 Apr 2023
Important dates
Leveraging mRNA Technology Workshop 2023
27 - 28 April 2023
Program Language
English
Location
Washington, DC, United States
Meeting type
Hybrid Meeting
Organizer

Leveraging mRNA Technology Workshop 2023

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 27 April 2023 

Opening - 1:05
1:05 PM EDT
Opening Lecture on mRNA Technology: Historical Perspective
Elie Dolgin, PhD
Independent Science Journalist, United States
Session 1: Basic Science of the mRNA Vaccine Technology - 1:30
1:30 PM EDT
Immunological Mechanisms of Durability for mRNA and Other Vaccines
Bali Pulendran, MD, PhD
Stanford University, United States
1:55 PM EDT
Differences Between DNA and RNA Vaccines
Deborah H. Fuller, PhD
University of Washington School of Medicine, United States
2:15 PM EDT
RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors
Karine Breckpot, PhD
Vrije Universiteit Brussel, Belgium
2:35 PM EDT
A New mRNA Format to Ease Its Application
Steve Pascolo, PhD, MD
University Hospital Zurich (USZ) / University of Zurich (UZH) / Miescher Pharma GmbH, Switzerland
Session 2: Current Applications for Infectious Diseases - mRNA Vaccines for COVID, Influenza, Malaria, Ebola, HIV, and RSV - 3:45
3:45 PM EDT
Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy
Matthew Gagne, PhD
Vaccine Research Center of the National Institutes of Health (NIH), United States
4:05 PM EDT
COVID-19 Variant Immunologic Landscape Trial (COVAIL)
Nadine Rouphael, MD, MSc, FSSCI, FIDSA
Emory University, United States
4:20 PM EDT
Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA
Norbert Pardi, PhD
University of Pennsylvania, United States
4:40 PM EDT
Clinical Update on mRNA Vaccines for Flu
M. Anthony Moody, MD
Duke Human Vaccine Institute, United States
4:55 PM EDT
mRNA Vaccines for HIV
Paolo Lusso, MD, PhD
National Institutes of Allergy and Infectious Diseases (NIAID), United States
5:15 PM EDT
Vaccines for Respiratory Syncytial Virus
Tracy Ruckwardt, PhD
Vaccine Research Center of the National Institutes of Health (NIH), United States

Day 2 - Friday, 28 April 2023

Session 3: Current Applications for Infectious Diseases - Clinical Considerations - 8:30
8:30 AM EDT
Immunogenicity of Lipid Carrier
Michela Locci, PhD
Perelman School of Medicine, University of Pennsylvania, United States
8:50 AM EDT
Safety Profiles of COVID-19 Vaccines
John R. Su, MD, PhD, MPH
Centers for Disease Control and Prevention, United States
9:10 AM EDT
Practical Consideration for Clinical Use of mRNA Vaccines
Diana Zhong, MD, MHS
Johns Hopkins University School of Medicine, United States
Session 4: Future Applications of the mRNA Technology - 10:20
10:20 AM EDT
Nucleic Acid Delivery Systems for RNA Therapy and Genome Editing
Daniel G. Anderson, PhD
Massachusetts Institute of Technology, United States
10:45 AM EDT
Polyvalent Vaccines
James Brien, PhD
Saint Louis University, United States
11:05 AM EDT
The Promise of mRNA to Deliver Human Monoclonal Antibodies
James E. Crowe, Jr., MD
Vanderbilt University Medical Center, United States
11:25 AM EDT
mRNA Formulations for Fetal and Maternal Therapy
Michael J. Mitchell, PhD
University of Pennsylvania, United States
11:45 AM EDT
Advances in Nucleic Acid Vaccine Technology
Anna Blakney, PhD, PEng
Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, Canada
Overview
Image
mRNA Workshop
About this Program

The inaugural edition of the Leveraging mRNA Technology Workshop successfully took place on 27 - 28 April 2023. 

The rapid development of mRNA COVID-19 vaccines is an unprecedented success for medicine and it heralds a new era in the development of vaccines for other (infectious) diseases.

The benefits and utility of this technology became quickly clear amongst academic research groups, public health as well as government agencies. Extensive clinical trials have confirmed the safety and efficacy of mRNA vaccines, and the principles of this technology have the potential to be applied to a wide range of other (infectious) diseases.

This might revolutionize the prevention and treatment of, for instance, cancer and many high priority infectious diseases (e.g., malaria, tuberculosis, and HIV), where other vaccine platforms have not been successful.

Compared to other vaccine platforms, mRNA vaccines show robust immune responses and have the potential to be designed and manufactured rapidly. However, there are still questions to be answered, for example regarding the durability of immunity provided.

The advances of mRNA vaccines come together with educational needs to comprehend technology, properties, benefits/limitations, applications to other diseases, and recent clinical data.

The program encompassed the pathway from target discovery and validation to (early) clinical development and use; and included mRNA modifications and delivery methods.

Program Directors
General Information 
Who Should Attend?
- Researchers in academic institutions/hospitals (basic, translational, clinical);
- Researchers from the pharmaceutical and biotech industry.
Meeting Objectives
The workshop aims to:

- Raise awareness, promote understating and stimulate discussion on the clinical application of mRNA technology
- Provide a global platform to foster cross-disciplinary interaction and knowledge exchange on the mRNA technology, its current clinical applications, and prospects
- Stimulate scientific interchange in an expert, independent and translational setting
Learning Objectives
After participating in this activity, participants will be able to:

- Summarize the latest advancement in mRNA and lipid nanoparticle biotechnology
- Reflect on the latest advancement in design and pre-clinical evaluations of novel vaccine candidates
- Describe clinical data supporting the use of mRNA-based vaccines for infectious diseases
- Comprehend key clinical considerations for the use of mRNA-based therapeutics in different populations and healthcare settings
- Reflect on prospects and limitations of mRNA-based vaccines for infectious diseases and beyond
Practical Information 
Venue
Address: 
Washington Marriott Georgetown
1221 22nd Street, NW
Washington D.C. 20037
United States

Distance from Ronald Reagan Washington National Airport (DCA): 4.5 miles

Distance from Washington Dulles International Airport (IAD): 28 miles
Accommodation
Accommodation is not included in the registration fee.

Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Language
The official language of the workshop is English. Translation will not be provided.
Enduring Materials
Workshop materials can be obtained upon registration at the registration desk at the Workshop Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Registration for the Leveraging mRNA Technology Workshop 2023 is closed.
Fees and Conditions

Regular Delegates*

Industry**

Standard Fee (payment before/ on 23 April 2023)

Free Registration

$395.00

Onsite Fee / Post-Meeting Fee (payment from 24 April 2023) 

Free Registration

$795.00

Discounts

NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates

Free Registration

Members of Endorsers

Free Registration

Sponsors

Contact the Secretariat

*Registration is free for the following participants: NGO Representatives, Advocates, Community Representatives, Policy Makers/ Government Representatives or Healthcare Professionals. Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV or other diseases.

**Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at Michelle.Wu@amededu.com

Important
  • We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
For onsite attendees:
- Access to all scientific sessions;
- Conference pack, including the program;
- Refreshments during the coffee breaks

For virtual attendees only:
- Access to all scientific sessions;
- Digital workshop pack, including the program;

IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Sponsored Attendance
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 31 March 2023 : 50% refund (minus an administration fee of €40)

- Cancellation after 31 March 2023: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 15 April 2023. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the workshop, the conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g., passport)
3. A letter from your assignment giver stating the details of your assignment (e.g., editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A discounted registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@virology-education.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Committees
Program Directors
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Support

Moderna has provided funding for this Independent Medical Education program.

Moderna has had no input into the selection of speakers or the content of the materials and presentations.

Endorsers
Become an Endorser

If you would like your organization to support this mRNA Workshop as an endorser or media partner, please contact Ms. Michelle Wu at Michelle.Wu@amededu.com.

Endorsers

The Leveraging the mRNA Technology Workshop 2023 is endorsed by the following organizations:

Venue
Venue

The confirmed venue details for the Leveraging mRNA Technology Workshop 2023 can be found below.

In case you have any questions or concerns regarding the venue, please feel free to contact us at Michelle.Wu@amededu.com

Media
Group Photo
mRNA2023_Group Photo
Promo Video
Your invitation to join us at the Leveraging the mRNA Technology Workshop 2023!
COVID-19

Health & Safety Measures regarding COVID-19

Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organized by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.

National Health & Safety Measures

The health and safety measures that will be taken by Virology Education during the Leveraging the mRNA Technology Workshop 2023 are listed on the government website of the United States. Please read them very carefully before traveling to the conference venue. These measures will be reviewed in accordance with the evolution of the pandemic.

Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at Michelle.Wu@amededu.com.

 

Traveling to the United States

Virology Education strongly advises participants to check the government website of the United States for the latest and most accurate information about the rules regarding travel.

Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc. 

What if I get ill during the event?

Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.